{
    "eid": "2-s2.0-85085019756",
    "title": "Schizophrenia phenomenology revisited: Positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia",
    "cover-date": "2021-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Deficit schizophrenia",
        "inflammation",
        "neuroimmune",
        "phenomenology",
        "symptom domains"
    ],
    "authors": [
        "Abbas F. Almulla",
        "Hussein K. Al-Hakeim",
        "Michael Maes"
    ],
    "citedby-count": 12,
    "ref-count": 52,
    "ref-list": [
        "Negative versus positive schizophrenia",
        "Affective, schizoaffective and schizophrenic psychoses. A comparative long-term study",
        "Negative symptoms in schizophrenia: A confirmatory factor analysis of competing models",
        "The two-syndrome concept: Origins and current status",
        "Are negative symptoms dimensional or categorical? Detection and validation of deficit schizophrenia with taxometric and latent variable mixture models",
        "The schedule for the deficit syndrome: An instrument for research in schizophrenia",
        "The diagnostic concept of schizophrenia: Its history, evolution, and future prospects",
        "Heterogeneity of schizophrenia: Genetic and symptomatic factors",
        "Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: Results of supervised machine learning",
        "Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: Results of unsupervised machine learning analysis",
        "In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde",
        "Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients",
        "Measuring thought disorder with clinical rating scales in schizophrenic and nonschizophrenic patients",
        "Thought, language, and communication in schizophrenia: Diagnosis and prognosis",
        "The cognitive neuroscience of thought disorder in schizophrenia",
        "Formal thought disorders: From phenomenology to neurobiology",
        "The positive and negative syndrome scale (PANSS) for schizophrenia",
        "The scale for the assessment of negative symptoms (SANS): Conceptual and theoretical foundations",
        "The brief psychiatric rating scale",
        "The assessment of anxiety states by rating",
        "A rating scale for depression",
        "\"Mini-mental status.\" A practical method for grading the cognitive state of patients for the clinician",
        "A new schizophrenia model: Immune activation is associated with the induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions",
        "Controlling the false discovery rate: A practical and powerful approach to multiple testing",
        "Testing and controlling for common method variance: A review of available methods",
        "A comparison of two approaches to correction of restriction of range in correlation analysis",
        "Restricted sample variance reduces generalizability",
        "Positive and negative symptoms in schizophrenia: A current overview",
        "Physio-somatic symptoms in schizophrenia: Association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway",
        "In schizophrenia, depression, anxiety, and physiosomatic symptoms are strongly related to psychotic symptoms and excitation, impairments in episodic memory, and increased production of neurotoxic tryptophan catabolites: A multivariate and machine learning study",
        "Upregulation of the intestinal paracellular pathway with breakdown of tight and adherens junctions in deficit schizophrenia",
        "The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence",
        "Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression",
        "Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries",
        "A review of vulnerability and risks for schizophrenia: Beyond the two-hit hypothesis",
        "The neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: A supervised machine learning study",
        "Breakdown of the paracellular tight and adherens junctions in the gut and blood brain barrier and damage to the vascular barrier in patients with deficit schizophrenia",
        "Deficit but not nondeficit schizophrenia is characterized by mucosa-associated activation of the tryptophan catabolite (TRYCAT) pathway with highly specific increases in IgA responses directed to picolinic, xanthurenic, and quinolinic acid",
        "Deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): A paradigm shift towards defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation",
        "Toward omics-based, systems biomedicine, and path and drug discovery methodologies for depression-inflammation research",
        "Clinical subtypes of unipolar depression: Part II. Quantitative and qualitative clinical differences between the vital and nonvital depression groups",
        "Construction of a neuro-immune-cognitive pathway-phenotype underpinning the phenome of deficit schizophrenia",
        "Dopamine in schizophrenia: A review and reconceptualization",
        "Implications of normal brain development for the pathogenesis of schizophrenia",
        "Program FACTOR at 10: Origins, development and future directions",
        "A general approach for fitting pure exploratory bifactor models",
        "Measuring depression over time . or not? Lack of unidimensionality and longitudinal measurement invariance in four common rating scales of depression"
    ],
    "affiliation": [
        {
            "affiliation-city": "Najaf",
            "@id": "60109789",
            "affilname": "The Islamic University, Najaf",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60109789",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Kufa",
            "@id": "60071160",
            "affilname": "University of Kufa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071160",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        }
    ],
    "funding": []
}